Governance Novavax, Inc.

NVAX

US6700024010

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-03-16 pm EDT			5-day change	1st Jan Change
10.08 ^USD	-1.51%		-4.45%	+50.00%

Mar. 10	Novavax, Inc. Presents at Leerink Global Healthcare Conference 2026, Mar-10-2026 03:40 PM
Mar. 03	Novavax, Inc. Presents at TD Cowen 46th Annual Health Care Conference, Mar-03-2026 02:30 PM

Executive Committee: Novavax, Inc.

Manager

Positions heldSince

John Jacobs

59 year

Chief Executive Officer	2023-01-22
President	2023-01-22

Robert Walker

Chief Tech/Sci/R&D Officer

2023-03-31

Luis Sanay

Investor Relations Contact

2024-08-31

Ruxandra Draghia Akli

61 year

Chief Tech/Sci/R&D Officer

2024-10-31

Ian J. Watkins

63 year

Human Resources Officer

2023-07-31

Mark Casey

63 year

General Counsel	2023-12-10
Corporate Secretary	2023-12-10

Seth Toback

Chief Tech/Sci/R&D Officer

2020-06-30

Raburn Mallory

Chief Tech/Sci/R&D Officer

2021-10-03

James Kelly

60 year

Director of Finance/CFO	2021-08-15
Treasurer	2021-08-15

Troy Morgan

Compliance Officer	2021-04-18
General Counsel	2024-07-31

Frank D. Czworka

57 year

Sales & Marketing

2020-07-01

Gale Smith

Chief Tech/Sci/R&D Officer

Composition of the Board of Directors: Novavax, Inc.

Director

CommitteesSince

Margaret McGlynn

66 year

Governance Committee	2012-07-09
Nominating Committee	2012-07-09
Compensation Committee Chair	2010-06-20
Audit Committee	2025-03-09
Governance Committee Chair	2025-03-09
Nominating Committee Chair	2025-03-09

Gregg Alton

60 year

Compensation Committee
Audit Committee Chair
Audit Committee	2020-12-13
Governance Committee
Nominating Committee
Nominating Committee Chair	2022-08-31

Richard Douglas

73 year

Executive Committee	2001-12-31
Audit Committee	2011-11-20
Compensation Committee	2011-11-20
Governance Committee
Nominating Committee

Rachel King

66 year

Compensation Committee	2024-11-11
Governance Committee	2018-10-31
Nominating Committee	2018-10-31
HR Committee	2024-11-11

Richard Rodgers

59 year

Compensation Committee	2022-12-07
Audit Committee Chair
Governance Committee
Nominating Committee

David Mott

60 year

Audit Committee
Compensation Committee Chair

Charles Newton

55 year

Compensation Committee Chair

2022-05-04

John Jacobs

59 year

Director/Board Member

2023-01-22

John Shiver

68 year

Director/Board Member	2025-03-09
Independent Dir/Board Member	2025-03-09

Latest Appointments: Novavax, Inc.

Feb. 26	Keros Therapeutics, Inc. Announces Board Changes, Effective March 9, 2026	CI
Jan. 07	Imunon, Inc. Announces Chief Financial Officer Changes, Effective January 14, 2026	CI
25-06-11	Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents	RE
25-06-11	Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents	RE
25-05-27	Novavax Inc - Eliminates COO Position, Terminates John Trizzino - SEC Filing	RE
25-05-27	Novavax, Inc. Announces Termination of John Trizzino as Chief Operating Officer, Effective as of June 20, 2025	CI
25-04-29	Novavax Appoints Charles Newton To Board Of Directors	RE

More news

Former Officers and Directors: Novavax, Inc.

Insider

Positions held

SinceUntil

James Young

Director/Board Member	2010-04-07	2011-04-19
Chairman	2011-04-19	2025-03-09
Independent Dir/Board Member	2010-04-06	2025-03-09

John Herrmann

Compliance Officer	-	2023-12-07
General Counsel	2010-05-27	2023-12-07
Corporate Secretary	2010-05-27	2023-12-07

Russell Wilson

Chief Tech/Sci/R&D Officer	2011-11-14	2012-03-27
Corporate Officer/Principal	2011-10-31	2023-10-31

Jill Hoyt

Chief Administrative Officer	2015-01-07	-
Human Resources Officer	2008-01-31	2023-09-30

Sven Arne Andréasson

Corporate Officer/Principal

2014-06-01

2023-04-30

Gregory Glenn

Chief Tech/Sci/R&D Officer

2010-07-06

2023-03-30

Stanley Erck

Director/Board Member	2011-04-19	2023-01-22
Chief Executive Officer	2011-04-19	2023-01-22
Chairman	2010-02-16	2011-04-19
President	2011-04-19	2023-01-22

Rajiv Indravadan Modi

Director/Board Member

2009-03-31

2022-03-04

Gary Evans

Director/Board Member	2007-03-31	2021-06-16
Chief Executive Officer	2005-03-31	2007-03-31
Chairman	2005-03-31	2007-03-31
Independent Dir/Board Member	2012-07-22	2021-06-16

Mervyn L. Hamer

Corporate Officer/Principal

2012-02-06

2019-07-31

Cynthia N. Oliver

Corporate Officer/Principal

2014-07-13

2017-12-31

Barclay Phillips

Director of Finance/CFO	2013-06-23	2017-11-09
Treasurer	2013-06-23	2017-11-09

Gail Boudreaux

Director/Board Member	2015-06-17	2017-11-04
Independent Dir/Board Member	2015-06-17	2017-11-04

Denise Giangola Courbron

Corporate Officer/Principal

2010-05-31

2016-10-31

Brian Rosen

General Counsel	2022-10-31	-
Corporate Officer/Principal	2015-03-16	-

John O. Marsh

Director/Board Member	1990-12-31	2014-06-11
Independent Dir/Board Member	1990-12-31	2014-06-11
Director/Board Member	-	2019-02-03

Fred Driscoll

Comptroller/Controller/Auditor	2009-12-01	2012-07-22
Director of Finance/CFO	2009-12-01	2013-05-16
Treasurer	2009-12-01	2013-05-16

Amy B. Fix

General Counsel

2013-03-31

John Trizzino

Corporate Officer/Principal	2011-09-05	2011-09-05
Chief Operating Officer	2023-11-19	2025-06-19
Director of Finance/CFO	2021-04-11	2021-08-15
Corporate Officer/Principal	2021-08-15	2023-11-19
President	2023-11-19	2025-06-19
Treasurer	2018-03-13	2020-06-28

Rahul Singhvi

Chief Executive Officer	2005-07-31	2011-04-18
Chief Operating Officer	2005-03-31	2005-07-31
Corporate Officer/Principal	2004-03-31	2005-03-31
President	2004-03-31	2011-04-18

Louis F. Fries

Chief Tech/Sci/R&D Officer	2011-03-31	-
Corporate Officer/Principal	2012-05-10	-

John A. Lambert

Director/Board Member	2010-02-16	2010-12-12
Chairman	2007-03-06	2010-02-16

Mark Owens Thornton

Chief Tech/Sci/R&D Officer

2010-05-24

Raymond Joseph Hage

Corporate Officer/Principal

2010-03-16

James M. Robinson

Corporate Officer/Principal

2010-01-10

Evdoxia E. Kopsidas

Comptroller/Controller/Auditor	2009-02-05	2009-11-26
Director of Finance/CFO	2009-02-05	2009-08-17

Thomas P. Monath

Director/Board Member

2006-09-01

2009-11-01

James Tananbaum

Director/Board Member

2005-12-31

2009-09-24

Susan B. Bayh

Director/Board Member

2005-07-20

Jeffrey Church

Director of Finance/CFO	2006-09-04	2007-04-19
Corporate Secretary	2006-09-04	2007-04-19
Treasurer	2006-09-04	2007-04-19

Denis M. O'Donnell

Director/Board Member

1990-12-31

2007-03-19

Len Stigliano

President

2007-02-28

Pincus Steven

Corporate Officer/Principal

2010-07-15

Penny M. Heaton

Chief Tech/Sci/R&D Officer

2006-10-08

Mitchell J. Kelly

Director/Board Member

2006-05-21

Dennis W. Genge

Director of Finance/CFO	-	2006-05-14
Treasurer	-	2006-05-14

J. Michael Lazarus

Director/Board Member

2006-04-25

Ronald H. Walker

Director/Board Member

2005-05-03

Nelson M. Sims

President

2005-01-01

Ford R. Lynch

Sales & Marketing

2003-09-30

Michael Ritz

Comptroller/Controller/Auditor

2001-06-30

2002-07-31

Jane E. Hager

Director/Board Member

1994-12-31

2001-12-31

Richard F. Maradie

Director/Board Member	1998-07-31	1998-07-31
President	-	1998-07-31

Michael McManus

Director/Board Member	1997-12-31	-
Independent Dir/Board Member	1997-12-31	-

Wouter W. Latour

Corporate Officer/Principal

Nita U. Patel

General Counsel

D. Craig Wright

Chief Tech/Sci/R&D Officer

Rajiv Sheel

Corporate Officer/Principal

Donald J. Macphee

Director of Finance/CFO

Rita M. Freedman

Corporate Officer/Principal

Maria Allende

Chief Tech/Sci/R&D Officer	2011-11-23	2012-05-10
Corporate Officer/Principal	2009-10-20	2011-11-23

Stephen L. Bandak

Chief Tech/Sci/R&D Officer	-	2011-09-18
General Counsel	-	2011-09-18
Corporate Officer/Principal	2011-09-18	-

Tricia J. Richardson

Investor Relations Contact	-	-
Public Communications Contact	2009-06-17	-

Jane L. Halpern

General Counsel	2011-11-20	-
Corporate Officer/Principal	2011-04-27	2011-11-20

Andrea Holtzman Drucker

General Counsel

Robert W. Lee

Corporate Officer/Principal

Mariann Caprino

Public Communications Contact

Jennifer L. Miller

Corporate Secretary

Rick A. Bright

Corporate Officer/Principal

Andrea N. Flynn

Investor Relations Contact	-	-
Public Communications Contact	-	-

Age distribution of managers

Parity Men Women

Male	23
Female	4

Of which Executive Committee

Male	12
Female	0

Of which Directors

Male	7
Female	2

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Companyâ€™s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.

Employees

749

Sector

Biotechnology & Medical Research

More about the company